Aspergillus Newsletter

eNewsletter: September 17th, 2009

Living with it, Working with it, Treating it

Logo

Having trouble reading this? Please open this file in a web browser or view it on our website.

In this issue

Useful links

Add This

Forgot password?

Get a reminder here

Coming Soon

Advances Against Aspergillosis 2010

Our Sponsors

Patients Section

Show Support

Show your support for the Fungal Research Trust - join our Facebook Causes group.

Sponsorship

We are always looking to increase our sponsorship. If you are interested in purchasing a sponsored link on the website (and a link on this mailing every month) Contact us

Demographics

The Aspergillus Website has 38000 registered members (9% Vets, 31% Medical, 23% Science) and provides up to 10 million page requests per year.

49% (9500) of professional members have purchasing authority.

36000 unique users (IP addresses) visit this website every month.

This Newsletter is sent out to 23000 members every month.

4000 websites link to the Aspergillus Website.

Website & Newsletter advertising

Prices for ads per page impression are outlined here. FROM £40 per month

Mobile Access

Mobile Content

Twitter AspergillusWeb

HonCode

This website is certified by Health On the Net Foundation. Click to verify.
We comply with the HONcode standard for trustworthy health information: verify here.


Clever cloak prevents immune recognition of airborne fungal spores

The air we breathe is filled with thousands of fungal spores (or conidia)Scanning EM of A.fumigatus showing hydrophobic rodlets per cubic metre, which in certain composting environments can easily exceed 10(9) per cubic metre. They originate from more than a hundred fungal species belonging mainly to the genera Cladosporium, Penicillium, Alternaria and Aspergillus. Although these conidia contain many antigens and allergens, it is not known why airborne fungal spores do not activate the host innate immune cells continuously and do not induce detrimental inflammatory responses following their inhalation. This report from a recent publication in Nature on Aspergillus fumigatus by Aimanianda et al have shown that a hydrophobic surface layer on the spores masks their recognition by the immune system and hence prevents immune responses. The surface of the dormant spore - known to be composed of a hydrophobic protein - RodA - covalently bound to the conidial cell wall, was demonstrated to be immunologically inert and did not induce dendritic cell or alveolar macrophage maturation and activation, and failed to activate helper T-cell immune responses in vivo. The removal of this surface layer either chemically (using hydrofluoric acid), or biologically at germination - resulted in inducing immune activation. These observations show that the hydrophobic rodlet layer on the conidial cell surface immunologically protects airborne aspergillus spores from detection.

This Month

The American Society for Microbiology 2009 ICAAC Young Investigator Awards, which recognizes and rewards early-career scientists for their research excellence and potential in microbiology and infectious diseases, has anounced that Tobias M. Hohl is to be honoured for his research on the interaction of Aspergillus fumigatus and the pulmonary innate immune system.

Whilst a Research Fellow at Memorial Sloan-Kettering Cancer Center, Hohl studied chemokine induction and signaling pathways in macrophages exposed to A. fumigatus.
Hohl continued his work by investigating the effect of echinocandin antifugals on the exposure of β-glucans on the surface of A. fumigatus conidia and hyphae. His research demonstrated that caspofungin and micafungin decrease β-glucan exposure on conidia but significantly increases β-glucan exposure on hyphae resulting in a significantly increased inflammatory response of macrophages and dendritic cells.

He is currently Assistant Professor at The Fred Hutchinson Cancer Research Center, and at the University of Washington, Seattle.

 

Latest News and Articles

New Guidelines:

The European Medicines Agency
has published draft guidelines on the "Clinical Evaluation of Antifungal agents for The Treatment and Prophylaxis of Invasive Fungal Disease" comments are invited before November 30th 2009, at the following address EWPSecretariat@emea.europa.eu .

There have been many additions to the articles section. We have picked out a few of the highlights here:

IL-6 is required for airway mucus production induced by inhaled fungal allergens

Allergic asthma is a chronic inflammatory disease of the airway that occurs in response to inhaled allergens such as ragweed pollen, cat dander, house dust mites, and fungi. A major feature of allergic airways disease is mucus metaplasia and mucus hypersecretion by airway epithelium which can physically obstruct the airways. Despite the association of increased IL-6 levels with human atopic asthma, the contribution of IL-6 to the development of allergic airway inflammation triggered by inhaled allergens remains unclear. Although IL-6 has been shown to be involved in in the effector function of CD4+ T cell subsets.

In this study, using a mouse model of allergic airway inflammation induced by direct airway exposure to extracts of Aspergillus fumigatus they showed that inhaled A. fumigatus extracts rapidly trigger the production of IL-6 in the airways. They also demonstrated that IL-6 is essential for mucus production by lung epithelial cells during allergic airway inflammation and therefore may represent a potential target for therapy in allergic pulmonary diseases.

A new secondary metabolite JBIR-15 has been isolated from Aspergillus sclerotiumSponge Mycale sp.

The new metabolite is an Aspochracin derivative and was isolated from a culture of A.sclerotium derived from a sea sponge - Mycale sp.
Sponge derived fungi are one of the most important resources of biologically active metabolites.



Predicting survival in adults with invasive aspergillosis during therapy for
hematological malignancies: Single-center analysis and validation of the Seattle, French, and Strasbourg prognostic indexes

The aims of this single-center study were to establish prognostic factors for survival (both aspergillosis-related and OS) after an IPA in all consecutive patients with IPA over a 13-year period, and, secondly to analyze (or validate) the potential usefulness of these three recent prognostic outcome studies in their patient cohort. IA was previously thought to be lethal in most with haematological malignancies. In this study many patients had a good outcome and prognostic groups were identifiable with simple variables assessed at the time of diagnosis. They indicate that the status of the underlying disease, patient comorbidities and laboratory markers of a poor immune status may be the variables which have the strongest impact on survival.

Reviews

New generation azole antifungals in clinical investigation

A comprehensive review of azole antifungals including detailed pharmokinetics, in vitro and in vivo studies, toxicity and drug interactions for all the second generation triazoles including the lesser known Isavuconazole, Ravuconazole and Albaconazole. Recently published by Corrado Girmenia, in Expert Opin. Investig. Drugs (2009), 18(9).

Aspergillosis in patients undergoing treatment with monoclonal antibodies

In light of the increasing use of new therapeutic agents that act by blocking specific immune pathways such as TNF-alpha blockers, IL-2 inhibitors and CD52 and CD20 blockers - this manuscript reviews the pathophysiology associated with an increased risk for aspergillosis in these patients, in addition to diagnostic and therapeutic considerations. (Rev Iberoam Micol.2009; 26(3): 175–183).

Images

Some excellent histology images showing aspergillus conidial heads inA.fumigatus conidial heads in lung tissue lung tissue from a patient with a suspicious lung nodule - which was eventually diagnosed as an aspergilloma contained in a lung bulla - can be viewed in both the aspergilloma section and microscopic pathology section of medical images. A full case history is attached to the images (case 076).

Jobs

5 jobs currently being advertised:

    1. Postdoctoral Research Associate Position, University of Wisconsin, USA
    2. Postdoctoral Research or Graduate Student position, Michigan State University, USA
    3. Postdoctoral Research or Graduate Student position, Yale University, USA
    4. Postdoctoral Research Assistant, University of Dundee, UK
    5. Postdoctoral Research Associate, Cramer Laboratory, Montana State University

Advertise your vacancy free of charge on the Aspergillus Website here

Air Quality

The latest EPA guidelines reviewing the impact of climate variability and change on aeroallergens and their associated effects can be viewed in the air quality section.

Case Histories

A new case history of a patient with emphysema who had a cough, chest pain and shortness of breath had a PET scan showed a suspicious lung nodule. When resected an aspergilloma in a lung bulla was diagnosed from histology. Many images including histology and CT scans are included. Case 076.

Education and Teaching

Many slide presentations from the recent meeting "Infocus -VIII forum de Infeccoes Fungicas na Pratica Clinica" held in Sao Paulo, Brazil on August 20-22nd 2009, can be viewed in the educational materials section under slide presentations.

Veterinary

An interesting article published in J. South African Vet Assoc. earlier this year has highlighted the dangers of feeding mouldy grain to sheep. A maize based brewers grain was fed along with a palatable hay to ewes and lambs in pens - the grain was visibly mouldy. After 14 days weakness and ataxia and tremors were noted. Six ewes then died within 7 days. At post mortem nephrosis and oxalate crystals were found in the renal tubules - this along with kidney failure was thought to be the cause. Amongst other fungi, Aspergillus niger was isolated from the contaminated feed - a species known to synthesise oxalates. Link .

Blog

Experimental evidence that antibiotics can trigger allergy and asthma
Tobias Hohl honoured for work on A.fumigatus
Risks of mycotoxins associated with hail damaged corn
Clever cloak prevents immune recognition of airborne fungal spores
Gabby comes home

Patients

We are asking for patients to send us any mould-free recipes they may have and recommend so we can make them available to all patients. If you have any send them here and we will upload them to the Aspergillus Support Group.

This month we continue our request for anyone interested in attending a meeting on aspergillosis specifically intended for patients and their friends, but also open to any other interested parties, to register their interest here. The idea is to inform patients about many aspects of their illness, all based on the latest findings with talks from several experts in these fields.

Interest has been good and we may have achieved sufficient numbers to consider going ahead with this idea. If anyone is still thinking about registering their interest it is not too late to register with no obligation. The more that register the easier it will be to ensure this goes ahead. Express an interest in the patients' meeting

There is a newly designed Patients website now entitled 'Aspergillosis Patient Support'. Much more comprehensive than before and easier to navigate but with the same successful support group and Q & A board

Donate

Please donateIt is now easy to donate to the Fungal Research Trust, a charity who principally fund the Aspergillus Website, run several patient support groups and fund research internationally.
If everyone who receives this newsletter gave £10 a year we could double our activities!

Please donate here.

Technical Tips

Our discussion group (email and/or website) designed to promote discussion on technical issues for laboratory workers.

Searching the website

There is now a third facility to search for information on Aspergillus. Covering all the information in the Aspergillus Website and including a series of websites we feel contain useful information NOT currently available on the Aspergillus Website, the Aspergillus World search engine contains large amounts of focussed information from all over the world. If you can suggest more (particularly keen to access information on industrial applications) then let us know at admin@aspergillus.org.uk.

RSS

Download our updates and articles automatically every time we add to those pages- no need to wait for the next newsletter. 40 000 pages accesses per month. Use RSS.
What is RSS and how do I use it? Get help here.

Twitter

You can now receive notification of updates to the Aspergillus Website on your mobile phone via SMS texting free of charge. Go to http://twitter.com/AspergillusWeb and open a Twitter account. Follow AspergillusWeb.

Thanks for reading!

Visit our website again soon.

The Aspergillus Team.

Contact us/Feedback